206 related articles for article (PubMed ID: 9001263)
1. Extended use of topical nasal decongestants.
Yoo JK; Seikaly H; Calhoun KH
Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Graf P
Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
[TBL] [Abstract][Full Text] [Related]
3. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
[TBL] [Abstract][Full Text] [Related]
5. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
Graf P; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
[TBL] [Abstract][Full Text] [Related]
6. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
Bielenberg J
Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
[No Abstract] [Full Text] [Related]
7. [The rebound of nasal resistance after decongestant used in nose].
Shen J; Huang X; Xiang J; Shu H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
[TBL] [Abstract][Full Text] [Related]
8. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
Knipping S; Holzhausen HJ; Riederer A; Bloching M
HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
[TBL] [Abstract][Full Text] [Related]
9. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
[TBL] [Abstract][Full Text] [Related]
10. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
[TBL] [Abstract][Full Text] [Related]
11. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
Druce HM; Ramsey DL; Karnati S; Carr AN
Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
[TBL] [Abstract][Full Text] [Related]
12. Paranasal sinusitis after long-term use of topical nasal decongestants.
Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
[TBL] [Abstract][Full Text] [Related]
13. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
Graf P; Hallén H; Juto JE
Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
[TBL] [Abstract][Full Text] [Related]
14. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
Graf P; Enerdal J; Hallén H
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
[TBL] [Abstract][Full Text] [Related]
15. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
Graf PM; Hallén H
Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
[TBL] [Abstract][Full Text] [Related]
16. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
[TBL] [Abstract][Full Text] [Related]
17. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
Yuta A; Ogawa Y
Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
[TBL] [Abstract][Full Text] [Related]
18. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
Cam B; Sari M; Midi A; Gergin O
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
[TBL] [Abstract][Full Text] [Related]
19. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
Ferguson BJ; Paramaesvaran S; Rubinstein E
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
[TBL] [Abstract][Full Text] [Related]
20. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
Graf P; Juto JE
Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
